Downregulation of DLC-1 gene by promoter methylation during primary colorectal cancer progression

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Peng, Haixia ^a   Long, Feng ^b   Wu, Zhiyuan ^b   Chu, Yimin ^a   Li, Ji ^a   Kuai, Rong ^a   Zhang, Jing ^b   Kang, Zhihua ^b   Zhang, Xinju ^b   Guan, Ming ^b  

^a Department of Gastroenterology   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; DLC 1 PROTEIN; K RAS PROTEIN; MESSENGER RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; DLC1 PROTEIN, HUMAN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER LOCALIZATION; CANCER RISK; CANCER SIZE; CANCER TISSUE; CARCINOGENESIS; CODON; COLON MUCOSA; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE SEVERITY; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE SILENCING; GENETIC RISK; HUMAN; HUMAN CELL; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METHYLATION SENSITIVE HIGH RESOLUTION MELTING ANALYSIS; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; PROMOTER REGION; PROTEIN FUNCTION; RECTUM MUCOSA; WILD TYPE; ADENOMA; COLORECTAL TUMOR; CPG ISLAND; DISEASE COURSE; DNA SEQUENCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; RISK FACTOR; SEQUENCE HOMOLOGY; TUMOR CELL LINE;

ADENOMA; BASE SEQUENCE; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CPG ISLANDS; DISEASE PROGRESSION; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GTPASE-ACTIVATING PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PROMOTER REGIONS, GENETIC; RISK FACTORS; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, NUCLEIC ACID; TUMOR SUPPRESSOR PROTEINS;

EID: 84874587717     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/181384     Document Type: Article

References (29)

1. Markowitz S. D., Bertagnolli M. M., Molecular basis of colorectal cancer. New England Journal of Medicine 2009 361 25 2404 2460 2-s2.0-72449176846 10.1056/NEJMra0804588
2. Baker S. J., Preisinger A. C., Jessup J. M., Paraskeva C., Markowitz S., Willson J. K. V., Hamilton S., Vogelstein B., p53 Gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Research 1990 50 23 7717 7722 2-s2.0-0025634118
3. Davies H., Bignell G. R., Cox C., Stephens P., Edkins S., Clegg S., Teague J., Woffendin H., Garnett M. J., Bottomley W., Davis N., Dicks E., Ewing R., Floyd Y., Gray K., Hall S., Hawes R., Hughes J., Kosmidou V., Menzies A., Mould C., Parker A., Stevens C., Watt S., Hooper S., Wilson R., Jayatilake H., Gusterson B. A., Cooper C., Shipley J., Hargrave D., Pritchard-Jones K., Maitland N., Chenevix-Trench G., Riggins G. J., Bigner D. D., Palmleri G., Cossu A., Flanagan A., Nicholson A., Ho J. W. C., Leung S. Y., Yuen S. T., Weber B. L., Seigler H. F., Darrow T. L., Paterson H., Marais R., Marshall C. J., Wooster R., Stratton M. R., Futreal P. A., Mutations of the BRAF gene in human cancer. Nature 2002 417 6892 949 954 2-s2.0-18444374405 10.1038/nature00766 (Pubitemid 34716871)
4. Forrester K., Almoguera C., Han K., Grizzle W. E., Perucho M., Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987 327 6120 298 303 2-s2.0-0023262990 (Pubitemid 17075080)
5. Goss K. H., Groden J., Biology of the adenomatous polyposis coli tumor suppressor. Journal of Clinical Oncology 2000 18 9 1967 1979 2-s2.0-0034098691 (Pubitemid 30261936)
6. Barault L., Charon-Barra C., Jooste V., De La Vega M. F., Martin L., Roignot P., Rat P., Bouvier A. M., Laurent-Puig P., Faivre J., Chapusot C., Piard F., Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Cancer Research 2008 68 20 8541 8546 2-s2.0-54249165951 10.1158/0008-5472.CAN-08-1171
7. Goodison S., Yuan J., Sloan D., Kim R., Li C., Popescu N. C., Urquidi V., The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. Cancer Research 2005 65 14 6042 6053 2-s2.0-22244443056 10.1158/0008-5472.CAN-04-3043 (Pubitemid 40994388)
8. Healy K. D., Hodgson L., Kim T. Y., Shutes A., Maddileti S., Juliano R. L., Hahn K. M., Harden T. K., Bang Y. J., Der C. J., DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms. Molecular Carcinogenesis 2008 47 5 326 337 2-s2.0-42949100728 10.1002/mc.20389 (Pubitemid 351614573)
9. Liao Y. C., Lo S. H., Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver. International Journal of Biochemistry and Cell Biology 2008 40 5 843 847 2-s2.0-40149083557 10.1016/j.biocel.2007.04.008 (Pubitemid 351329658)
10. Yuan B. Z., Miller M. J., Keck C. L., Zimonjic D. B., Thorgeirsson S. S., Popescu N. C., Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Research 1998 58 10 2196 2199 2-s2.0-0032524031 (Pubitemid 28232908)
11. Yuan B. Z., Zhou X., Durkin M. E., Zimonjic D. B., Gumundsdottir K., Eyfjord J. E., Thorgeirsson S. S., Popescu N. C., DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity. Oncogene 2003 22 3 445 450 2-s2.0-0037461932 10.1038/sj.onc.1206064 (Pubitemid 36194340)
12. Zhou X., Thorgeirsson S. S., Popescu N. C., Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells. Oncogene 2004 23 6 1308 1313 2-s2.0-1442278561 10.1038/sj.onc.1207246 (Pubitemid 38297186)
13. Durkin M. E., Yuan B. Z., Zhou X., Zimonjic D. B., Lowy D. R., Thorgeirsson S. S., Popescu N. C., DLC-1: a Rho GTPase-activating protein and tumour suppressor. Journal of Cellular and Molecular Medicine 2007 11 5 1185 1207 2-s2.0-35648981592 10.1111/j.1582-4934.2007.00098.x (Pubitemid 350037059)
14. Ullmannova V., Popescu N. C., Expression profile of the tumor suppressor genes DLC-1 and DLC-2 in solid tumors. International Journal of Oncology 2006 29 5 1127 1132 2-s2.0-34347333532
15. Kim T. Y., Jong H. S., Song S. H., Dimtchev A., Jeong S. J., Lee J. W., Kim T. Y., Kim N. K., Jung M., Bang Y. J., Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells. Oncogene 2003 22 25 3943 3951 2-s2.0-0038001053 10.1038/sj.onc.1206573 (Pubitemid 36819668)
16. Wong C. M., Lee J. M. F., Ching Y. P., Jin D. Y., Ng I. O. L., Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma. Cancer Research 2003 63 22 7646 7651 2-s2.0-0344844475
17. Yuan B. Z., Durkin M. E., Popescu N. C., Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers. Cancer Genetics and Cytogenetics 2003 140 2 113 117 2-s2.0-0037438985 10.1016/S0165-4608(02)00674-X (Pubitemid 36349010)
18. Yuan B. Z., Jefferson A. M., Baldwin K. T., Thorgeirsson S. S., Popescu N. C., Reynolds S. H., DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas. Oncogene 2004 23 7 1405 1411 2-s2.0-1442308355 10.1038/sj.onc.1207291 (Pubitemid 38406835)
19. Guan M., Zhou X., Soulitzis N., Spandidos D. A., Popescu N. C., Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications. Clinical Cancer Research 2006 12 5 1412 1419 2-s2.0-33645058409 10.1158/1078-0432.CCR-05-1906
20. Pichler M., Balic M., Stadelmeyer E., Ausch C., Wild M., Guelly C., Bauernhofer T., Samonigg H., Hoefler G., Dandachi N., Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors. Journal of Molecular Diagnostics 2009 11 2 140 147 2-s2.0-64249106774 10.2353/jmoldx.2009.080100
21. Zhang C., Guo W., Wu J., Song B., Dai Q., Pan B., Ji Y., Guo J., Differential high-resolution melting analysis for the detection of K-ras codons 12 and 13 mutations in pancreatic cancer. Pancreas 2011 40 8 1283
22. Chlebowski R. T., Wactawski-Wende J., Ritenbaugh C., Hubbell F. A., Ascensao J., Rodabough R. J., Rosenberg C. A., Taylor V. M., Harris R., Chen C., Adams-Campbell L. L., White E., Estrogen plus progestin and colorectal cancer in postmenopausal women. New England Journal of Medicine 2004 350 10 991 1004 2-s2.0-10744220122 10.1056/NEJMoa032071 (Pubitemid 38269276)
23. Liu J. B., Zhang S. Q., Shi M. X., Shao B. F., Zhang Y. X., Relationship between methylation status of DLC-1 gene and metastasis of hepatocellular carcinoma. World Chinese Journal of Digestology 2008 16 11 1237 1240 2-s2.0-47249094951
24. Jin Y., Tian X., Shang Y., Huang P., Inhibition of DLC-1 gene expression by RNA interference in the colon cancer Lo Vo cell line. Oncology Reports 2008 19 3 669 674 2-s2.0-40249094998 (Pubitemid 351330434)
25. Kang Z., Xu F., Zhang Q. A., Lin J., Wu Z., Zhang X., Luo Y., Xu J., Guan M., Correlation of DLC1 gene methylation with oncogenic PIK3CA mutations in extramammary Paget's disease. Modern Pathology 2012 25 8 1160 1168
26. Carragher L. A. S., Snell K. R., Giblett S. M., Aldridge V. S. S., Patel B., Cook S. J., Winton D. J., Marais R., Pritchard C. A., V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a. EMBO Molecular Medicine 2010 2 11 458 471 2-s2.0-78649307591 10.1002/emmm.201000099
27. Kwon O., Jeong S. J., Kim S. O., He L., Lee H. G., Jang K. L., Osada H., Jung M., Kim B. Y., Ahn J. S., Modulation of E-cadherin expression by K-Ras; involvement of DNA methyltransferase-3b. Carcinogenesis 2010 31 7 1194 1201 2-s2.0-77954358329 10.1093/carcin/bgq071
28. Tannapfel A., Benicke M., Katalinic A., Uhlmann D., Kockerling F., Hauss J., Wittekind C., Frequency of p16(INK4A) alterations and k-ras mutations in intrahepatic cholangiocarcinoma of the liver. Gut 2000 47 5 721 727 2-s2.0-0033756536 10.1136/gut.47.5.721
29. Guan R. J., Fu Y., Holt P. R., Pardee A. B., Association of K-ras mutations with p16 methylation in human colon cancer. Gastroenterology 1999 116 5 1063 1071 2-s2.0-0032937784 10.1016/S0016-5085(99)70009-0 (Pubitemid 29203016)